Big Bite: Biden demands insurance companies cover medical "gender-affirming care" after the FDA added a warning to puberty blockers
Big bite | A detailed dive into big news
July 1
On July 1, the Food and Drug Administration (FDA) added a warning to multiple gonadotropin-releasing hormone (GnRH) agonists, drugs often used as puberty blockers in gender-confused youth.
The FDA identified six cases where there was a “plausible” link between GnRH agonists and a condition called pseudotumor cereb…
